MD-Bio is a leader in innovative diagnostic solutions, specializing in harm reduction test kits for Fentanyl and Xylazine detection, as well as advanced diagnostics for biothreats and emerging diseases. By combining cutting-edge technology with practical, field-ready tools, MD-Bio is at the forefront of safeguarding public health. From combating the opioid crisis to detecting critical pathogens, MD-Bio delivers reliable, accessible solutions that empower communities, healthcare providers, and first responders. Dedicated to innovation and impact, MD-Bio strives to protect lives and address the evolving challenges of global health.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 120 Industrial Blvd, Sugar Land,texas 77478,united States
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://mdbio.com/
- Keywords
- Administration (SAMHSA).
- HQ
- Sugar Land, Texas
Md-Bio Questions
Md-Bio's website is https://mdbio.com/
Md-Bio's LinkedIn profile is https://www.linkedin.com/company/md-bio-incorporated
Md-Bio has
7 employees.
View email and phone details for 7
employees at Md-Bio.
Md-Bio's industry is
Medical Equipment Manufacturing
Md-Bio's top competitors are
Jiangsu Micsafe Medical Technology Co., Ltd,
Shoreup,
Dottlink,
Bogardus Medical Systems, Inc,
Beepurple,
Helpucompli,
Detectachem,
Apothicom,
Ajosha Bioteknik Private Limited,
Lochness Medical Inc..
Md-Bio's categories are Medical Equipment Manufacturing
Md-Bio's founding year is 2020
